Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.19
EARNINGS PER SHARE (EPS) AVG 3Y
-0.10
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
iTonic Holdings Ltd.
Market Cap
$25.43M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.19
3Y Avg
-0.10
5Y Avg
N/A
Market Cap
$26.55M
Earnings Per Share (EPS)
-0.50
TTM Avg
-0.76
3Y Avg
-1.17
5Y Avg
-2.27
Market Cap
$24.96M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.41
3Y Avg
-1.95
5Y Avg
-2.99
Market Cap
$27.21M
Earnings Per Share (EPS)
-2.41
TTM Avg
-9.11
3Y Avg
-20.57
5Y Avg
-19.82
Market Cap
$24.74M
Earnings Per Share (EPS)
-4.34
TTM Avg
-3.52
3Y Avg
-3.45
5Y Avg
-7.67
Market Cap
$23.96M
Earnings Per Share (EPS)
N/A
TTM Avg
22.45
3Y Avg
9.70
5Y Avg
5.59
Market Cap
$28.62M
Earnings Per Share (EPS)
-0.62
TTM Avg
-0.83
3Y Avg
-1.05
5Y Avg
-1.29
Market Cap
$22.87M
Earnings Per Share (EPS)
-1.83
TTM Avg
-2.73
3Y Avg
-3.73
5Y Avg
-3.47
Market Cap
$29.44M
Earnings Per Share (EPS)
-1.63
TTM Avg
-2.10
3Y Avg
-19.25
5Y Avg
-13.48
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iTonic Holdings Ltd. (ITOC) | $25.43M | N/A | -0.19 | -0.10 | N/A |
| InspireMD, Inc. (NSPR)vs › | $26.55M | -0.50 | -0.76 | -1.17 | -2.27 |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.96M | -0.29 | -0.41 | -1.95 | -2.99 |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.21M | -2.41 | -9.11 | -20.57 | -19.82 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.74M | -4.34 | -3.52 | -3.45 | -7.67 |
| Kyntra Bio, Inc. (KYNB)vs › | $23.96M | N/A | 22.45 | 9.70 | 5.59 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.62M | -0.62 | -0.83 | -1.05 | -1.29 |
| Rein Therapeutics Inc. (RNTX)vs › | $22.87M | -1.83 | -2.73 | -3.73 | -3.47 |
| OneMedNet Corporation (ONMD)vs › | $29.44M | -1.63 | -2.10 | -19.25 | -13.48 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.65M | -1.66 | -1.66 | -2.82 | -25.82 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.32 |
| 2024-12-31 | -0.05 |
| 2023-12-31 | -0.02 |
| 2022-12-31 | 0.01 |
| 2021-12-31 | 0.01 |
